Opus Genetics, Inc. (IRD)
4.23
+0.03
(+0.71%)
USD |
NASDAQ |
Nov 10, 16:00
4.24
+0.01
(+0.24%)
After-Hours: 20:00
Opus Genetics Market Cap : 349.60M for Nov. 10, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 10, 2026 | 349.60M |
| November 09, 2026 | 347.12M |
| November 06, 2026 | 345.47M |
| November 05, 2026 | 331.00M |
| November 04, 2026 | 352.91M |
| November 03, 2026 | 324.81M |
| November 02, 2026 | 305.80M |
| October 30, 2026 | 303.32M |
| October 29, 2026 | 301.66M |
| October 28, 2026 | 304.14M |
| October 27, 2026 | 285.96M |
| October 26, 2026 | 274.39M |
| October 23, 2026 | 286.79M |
| October 22, 2026 | 315.72M |
| October 21, 2026 | 340.10M |
| October 20, 2026 | 331.42M |
| October 19, 2026 | 315.72M |
| October 16, 2026 | 317.37M |
| October 15, 2026 | 334.72M |
| October 14, 2026 | 338.86M |
| October 13, 2026 | 350.43M |
| October 12, 2026 | 383.49M |
| October 09, 2026 | 384.31M |
| October 08, 2026 | 368.61M |
| October 07, 2026 | 364.48M |
| Date | Value |
|---|---|
| October 06, 2026 | 362.00M |
| October 05, 2026 | 362.00M |
| October 02, 2026 | 378.53M |
| October 01, 2026 | 372.74M |
| September 30, 2026 | 400.02M |
| September 29, 2026 | 409.52M |
| September 28, 2026 | 417.37M |
| September 25, 2026 | 393.40M |
| September 24, 2026 | 402.50M |
| September 23, 2026 | 399.19M |
| September 22, 2026 | 426.46M |
| September 21, 2026 | 431.42M |
| September 18, 2026 | 428.12M |
| September 17, 2026 | 436.38M |
| September 16, 2026 | 447.13M |
| September 15, 2026 | 481.01M |
| September 14, 2026 | 493.41M |
| September 11, 2026 | 499.19M |
| September 10, 2026 | 501.67M |
| September 09, 2026 | 473.57M |
| September 08, 2026 | 358.69M |
| September 04, 2026 | 385.97M |
| September 03, 2026 | 380.18M |
| September 02, 2026 | 367.78M |
| September 01, 2026 | 316.54M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Rezolute, Inc. | 388.82M |
| Faeth Therapeutics, Inc. | 333.88M |
| Nuvectis Pharma, Inc. | 541.27M |
| ACADIA Pharmaceuticals, Inc. | 3.159B |
| Alnylam Pharmaceuticals, Inc. | 20.30B |
Market Cap Related Metrics
| PS Ratio | 49.44 |
| Price to Book Value | 10.54 |
| Price | 4.23 |
| Earnings Yield | -37.50% |